Search Results - "Ozaki, Michelle K"

Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes by Jindal, Sonali, Pennock, Nathan D., Sun, Duanchen, Horton, Wesley, Ozaki, Michelle K., Narasimhan, Jayasri, Bartlett, Alexandra Q., Weinmann, Sheila, Goss, Paul E., Borges, Virginia F., Xia, Zheng, Schedin, Pepper

“…Young women’s breast cancer (YWBC) has poor prognosis and known interactions with parity. Women diagnosed within 5–10 years of childbirth, defined as…”
Get full text

Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors by Weiss, Jonathan M, Davies, Luke C, Karwan, Megan, Ileva, Lilia, Ozaki, Michelle K, Cheng, Robert Ys, Ridnour, Lisa A, Annunziata, Christina M, Wink, David A, McVicar, Daniel W

“…Control of cellular metabolism is critical for efficient cell function, although little is known about the interplay between cell subset-specific metabolites…”
Get full text

Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model by Harrington, Brittney S., Ozaki, Michelle K., Caminear, Michael W., Hernandez, Lidia F., Jordan, Elizabeth, Kalinowski, Nicholas J., Goldlust, Ian S., Guha, Rajarshi, Ferrer, Marc, Thomas, Craig, Shetty, Jyoti, Tran, Bao, Wong, Nathan, House, Carrie D., Annunziata, Christina M.

“…Disease recurrence is the major cause of morbidity and mortality of ovarian cancer (OC). In terms of maintenance therapies after platinum-based chemotherapy,…”
Get full text

Abstract A046: Liver involution generates a pro-metastatic niche in a murine model of postpartum breast cancer liver metastasis by Ozaki, Michelle K, Zhang, Yi, Xi, Zheng, Schedin, Pepper

“…Abstract Postpartum breast cancer (PPBC), cases diagnosed within 10 years of childbirth, has increased risk of liver metastases. Our lab has shown that the…”
Get full text

Abstract 112: Identifying drugs that target ovarian cancer tumor initiating cells by Ozaki, Michelle K., House, Carrie D., Annunziata, Christina M.

“…Abstract Ovarian cancer is the most lethal gynecological cancer, with overall five-year survival for women with advanced disease being at only 25%. The current…”
Get full text

Abstract 983: RNA-seq analysis of murine liver to identify breast cancer metastatic potential during liver involution by Ozaki, Michelle K., Bartlett, Alexandra Q., Xia, Zheng, Schedin, Pepper

“…Abstract Background: Postpartum breast cancer (PPBC), variably defined as breast cancer diagnosed within 5-10 years after a patient’s last pregnancy, has…”
Get full text

Abstract 167: Targeting the NF-kappaB pathway with bardoxolone methyl to inhibit ovarian cancer spheroid formation by Ozaki, Michelle K., House, Carrie D., Mazan-Mamczarz, Krystyna, Lal-Nag, Madhu, Thomas, Craig, Annunziata, Christina M.

“…Abstract Over 70% of patients with advanced stage ovarian cancer relapse within 2 years, with long term overall survival being only 25%. Tumor-initiating cells…”
Get full text